Genoil (GNOLF) Cash & Equivalents (2009 - 2025)

Genoil (GNOLF) has 15 years of Cash & Equivalents data on file, last reported at $12.0 in Q4 2025.

• On a quarterly basis, Cash & Equivalents fell 99.9% year-over-year to $12.0 in Q4 2025; TTM through Dec 2025 was $12.0, a 99.9% decrease from a year earlier, with the FY2025 full-year figure at $12.0, down 99.9% from the prior year.
• Cash & Equivalents for Q4 2025 stood at $12.0, down from $10881.0 in the prior quarter.
• Over the last five years, Cash & Equivalents for GNOLF reached as high as $54153.0 in Q1 2025 and fell as low as $0.01 in Q3 2021.
• Historically, Cash & Equivalents has averaged $14440.2 across 5 years, with a median of $10672.5 in 2023.
• Across the five-year window, Cash & Equivalents sank 100.0% in 2021 and surged 399364547.15% in 2022, its largest moves.
• Year by year, Cash & Equivalents stood at $12.0 in 2021, then surged by 41933.33% to $5044.0 in 2022, then surged by 107.45% to $10464.0 in 2023, then rose by 15.02% to $12036.0 in 2024, then tumbled by 99.9% to $12.0 in 2025.
• Per Business Quant data, the three most recent Cash & Equivalents figures were $12.0 in Q4 2025, $10881.0 in Q3 2025, and $41938.0 in Q2 2025.